SLC25A18

gene
On this page

Summary

SLC25A18 (solute carrier family 25 member 18, HGNC:10988) is a protein-coding gene on chromosome 22q11.21, encoding Mitochondrial glutamate carrier 2 (Q9H1K4). Responsible for the transport of glutamate from the cytosol into the mitochondrial matrix with the concomitant import of a proton (symport system).

Enables amino acid:proton symporter activity. Involved in L-glutamate transmembrane transport. Located in mitochondrion.

Source: NCBI Gene 83733 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 16 total
  • MANE Select transcript: NM_031481

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:10988
Approved symbolSLC25A18
Namesolute carrier family 25 member 18
Location22q11.21
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000182902
Ensembl biotypeprotein_coding
OMIM609303
Entrez83733

Gene structure

Transcript identifiers

Ensembl transcripts: 35 — 31 protein_coding, 3 protein_coding_CDS_not_defined, 1 retained_intron

ENST00000327451, ENST00000399813, ENST00000467228, ENST00000469889, ENST00000496051, ENST00000497401, ENST00000907596, ENST00000907597, ENST00000907598, ENST00000907599, ENST00000907600, ENST00000907601, ENST00000907602, ENST00000907603, ENST00000907604, ENST00000907605, ENST00000907606, ENST00000907607, ENST00000907608, ENST00000907609, ENST00000907610, ENST00000907611, ENST00000907612, ENST00000907613, ENST00000907614, ENST00000907615, ENST00000907616, ENST00000907617, ENST00000907618, ENST00000907619, ENST00000925887, ENST00000943247, ENST00000943248, ENST00000943249, ENST00000943250

RefSeq mRNA: 2 — MANE Select: NM_031481 NM_001303484, NM_031481

CCDS: CCDS13744

Canonical transcript exons

ENST00000327451 — 11 exons

ExonStartEnd
ENSE000012989161758713617587301
ENSE000013111061758792517588079
ENSE000013125721758341617583534
ENSE000013215061758959017589665
ENSE000014331261756992417569986
ENSE000019559741756349817563713
ENSE000034753451758135817581413
ENSE000035329161758103717581159
ENSE000035584981758256317582653
ENSE000036633811757974517579964
ENSE000037087161759009517590995

Expression profiles

Bgee: expression breadth ubiquitous, 186 present calls, max score 97.61.

FANTOM5 (CAGE): breadth broad, TPM avg 3.9110 / max 213.2844, expressed in 210 samples.

FANTOM5 promoters (6 alternative TSS)

Promoter IDTPM avgSamples expressed
1909811.8839126
1909780.9005138
1909790.427799
1909830.4100102
1909800.153375
1909820.135661

Top tissues by expression

253 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
medial globus pallidusUBERON:000247797.61gold quality
amygdalaUBERON:000187697.36gold quality
putamenUBERON:000187496.89gold quality
globus pallidusUBERON:000187596.86gold quality
caudate nucleusUBERON:000187396.68gold quality
right lobe of liverUBERON:000111496.67gold quality
nucleus accumbensUBERON:000188296.37gold quality
temporal lobeUBERON:000187196.16gold quality
substantia nigraUBERON:000203895.91gold quality
entorhinal cortexUBERON:000272895.60gold quality
right frontal lobeUBERON:000281095.56gold quality
anterior cingulate cortexUBERON:000983595.41gold quality
lateral globus pallidusUBERON:000247695.27gold quality
Ammon’s hornUBERON:000195495.24gold quality
midbrainUBERON:000189195.16gold quality
hypothalamusUBERON:000189895.06gold quality
Brodmann (1909) area 9UBERON:001354094.36gold quality
endothelial cellCL:000011594.20gold quality
dorsolateral prefrontal cortexUBERON:000983493.71gold quality
liverUBERON:000210793.69gold quality
superior frontal gyrusUBERON:000266193.63gold quality
postcentral gyrusUBERON:000258193.50gold quality
primary visual cortexUBERON:000243693.09gold quality
frontal cortexUBERON:000187092.91gold quality
substantia nigra pars reticulataUBERON:000196692.82gold quality
cerebral cortexUBERON:000095692.75gold quality
neocortexUBERON:000195092.46gold quality
parietal lobeUBERON:000187292.32gold quality
prefrontal cortexUBERON:000045192.31gold quality
middle temporal gyrusUBERON:000277191.97gold quality

Single-cell (SCXA)

Detected in 3 experiment(s), a significant marker in 2.

ExperimentMarker?Max mean expression
E-HCAD-25yes23.56
E-GEOD-84465yes12.64
E-ANND-3no2.78

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

40 targeting SLC25A18, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-450099.9972.722367
HSA-LET-7A-5P99.9872.291790
HSA-LET-7B-5P99.9872.311790
HSA-LET-7C-5P99.9872.291790
HSA-LET-7E-5P99.9872.291790
HSA-LET-7F-5P99.9872.561784
HSA-LET-7G-5P99.9872.371784
HSA-LET-7I-5P99.9872.371788
HSA-MIR-98-5P99.9872.331787
HSA-LET-7D-5P99.9671.761632
HSA-MIR-445899.9671.641650
HSA-MIR-651-3P99.9473.485177
HSA-MIR-205-3P99.9269.923165
HSA-MIR-568099.9169.833421
HSA-MIR-629-3P99.8567.991875
HSA-MIR-3121-3P99.8271.963630
HSA-MIR-374C-5P99.8072.062910
HSA-MIR-655-3P99.8072.192909
HSA-MIR-4713-5P99.7867.801794
HSA-MIR-6848-3P99.6466.49885
HSA-MIR-653-5P99.4667.351300
HSA-MIR-6843-3P99.2666.42915
HSA-MIR-371A-5P99.0866.511914
HSA-MIR-670-3P99.0368.882404
HSA-MIR-5088-3P98.2966.631310
HSA-MIR-63797.9164.051517
HSA-MIR-4446-3P97.9164.29991
HSA-MIR-7113-5P97.8867.331735
HSA-MIR-429497.8665.721110
HSA-MIR-94397.8164.42694

Literature-anchored findings (GeneRIF, showing 3)

  • The genes CECR2, SLC25A18 and ATP6V1E1, mapping within the critical region for cat eye syndrome (CES), may be responsible for anorectal, renal and preauricular anomalies in patients with CES. (PMID:22395867)
  • Compares and contrasts all the known human SLC25A* genes and includes functional information. (PMID:23266187)
  • Increased expression of SLC25A18 is associated with Alzheimer’s disease and is involved in Abeta42-induced mitochondrial dysfunction and apoptosis in neuronal cells. (PMID:38871013)

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
mus_musculusSlc25a18ENSMUSG00000004902
rattus_norvegicusSlc25a18ENSRNOG00000042731

Paralogs (49): SLC25A13 (ENSG00000004864), SLC25A5 (ENSG00000005022), SLC25A39 (ENSG00000013306), SLC25A40 (ENSG00000075303), SLC25A3 (ENSG00000075415), SLC25A43 (ENSG00000077713), SLC25A24 (ENSG00000085491), SLC25A1 (ENSG00000100075), SLC25A17 (ENSG00000100372), SLC25A14 (ENSG00000102078), SLC25A15 (ENSG00000102743), SLC25A11 (ENSG00000108528), UCP1 (ENSG00000109424), SLC25A36 (ENSG00000114120), SLC25A12 (ENSG00000115840), SLC25A2 (ENSG00000120329), SLC25A51 (ENSG00000122696), SLC25A16 (ENSG00000122912), SLC25A35 (ENSG00000125434), SLC25A19 (ENSG00000125454), SLC25A23 (ENSG00000125648), SLC25A47 (ENSG00000140107), SLC25A52 (ENSG00000141437), SLC25A38 (ENSG00000144659), SLC25A26 (ENSG00000144741), SLC25A48 (ENSG00000145832), SLC25A37 (ENSG00000147454), SLC25A25 (ENSG00000148339), SLC25A31 (ENSG00000151475), SLC25A4 (ENSG00000151729), SLC25A27 (ENSG00000153291), SLC25A28 (ENSG00000155287), SLC25A44 (ENSG00000160785), SLC25A45 (ENSG00000162241), SLC25A34 (ENSG00000162461), SLC25A32 (ENSG00000164933), SLC25A6 (ENSG00000169100), SLC25A33 (ENSG00000171612), SLC25A30 (ENSG00000174032), UCP3 (ENSG00000175564)

Protein

Protein identifiers

Mitochondrial glutamate carrier 2Q9H1K4 (reviewed: Q9H1K4)

Alternative names: Glutamate/H(+) symporter 2, Solute carrier family 25 member 18

All UniProt accessions (1): Q9H1K4

UniProt curated annotations — full annotation on UniProt →

Function. Responsible for the transport of glutamate from the cytosol into the mitochondrial matrix with the concomitant import of a proton (symport system).

Subcellular location. Mitochondrion inner membrane.

Tissue specificity. Expressed in brain, to a lesser extent in testis, and poorly in all the other tissues.

Similarity. Belongs to the mitochondrial carrier (TC 2.A.29) family.

RefSeq proteins (2): NP_001290413, NP_113669* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR002067MCPFamily
IPR018108MCP_transmembraneRepeat
IPR023395MCP_dom_sfHomologous_superfamily
IPR051028Mito_Solute_CarrierFamily

Pfam: PF00153

Catalyzed reactions (Rhea), 1 shown:

  • L-glutamate(in) + H(+)(in) = L-glutamate(out) + H(+)(out) (RHEA:70955)

UniProt features (13 total): transmembrane region 6, repeat 3, chain 1, region of interest 1, compositionally biased region 1, modified residue 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9H1K4-F173.240.00

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (1): 145

Function

Pathways and Gene Ontology

Reactome pathways

3 pathways

IDPathway
R-HSA-442660SLC-mediated transport of neurotransmitters
R-HSA-9856872Malate-aspartate shuttle
R-HSA-428643Organic anion transport by SLC5/17/25 transporters

MSigDB gene sets: 108 (showing top): GSE45365_NK_CELL_VS_CD8A_DC_MCMV_INFECTION_UP, GOBP_ORGANOPHOSPHATE_METABOLIC_PROCESS, GOBP_AMINO_ACID_TRANSMEMBRANE_TRANSPORT, GOBP_NADPLUS_METABOLIC_PROCESS, GOBP_MONOATOMIC_CATION_TRANSPORT, GOBP_ORGANIC_ACID_TRANSPORT, GOBP_NUCLEOBASE_CONTAINING_SMALL_MOLECULE_METABOLIC_PROCESS, GOBP_AMINO_ACID_TRANSPORT, GOBP_ORGANIC_ANION_TRANSPORT, GGGNNTTTCC_NFKB_Q6_01, GOCC_MITOCHONDRIAL_ENVELOPE, GOBP_DICARBOXYLIC_ACID_TRANSPORT, GOMF_PROTON_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, GOBP_ACIDIC_AMINO_ACID_TRANSPORT, GFI1_01

GO Biological Process (7): monoatomic ion transport (GO:0006811), aspartate transmembrane transport (GO:0015810), L-glutamate transmembrane transport (GO:0015813), malate-aspartate shuttle (GO:0043490), transmembrane transport (GO:0055085), L-aspartate transmembrane transport (GO:0070778), proton transmembrane transport (GO:1902600)

GO Molecular Function (5): amino acid:proton symporter activity (GO:0005280), L-glutamate transmembrane transporter activity (GO:0005313), L-aspartate transmembrane transporter activity (GO:0015183), protein binding (GO:0005515), symporter activity (GO:0015293)

GO Cellular Component (3): mitochondrion (GO:0005739), mitochondrial inner membrane (GO:0005743), membrane (GO:0016020)

Reactome top-level categories

Rollup of top-3 pathways:

CategoryPathways
SLC-mediated transmembrane transport1
Respiratory electron transport1
SLC-mediated transport of organic anions1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
transport2
L-alpha-amino acid transmembrane transport2
acidic amino acid transmembrane transporter activity2
L-amino acid transmembrane transporter activity2
amino acid transmembrane transport1
C4-dicarboxylate transport1
acidic amino acid transport1
nitrogen compound transport1
carboxylic acid transmembrane transport1
L-glutamate import1
L-aspartate:2-oxoglutarate transaminase activity1
NAD+ metabolic process1
L-malate dehydrogenase (NAD+) activity1
mitochondrial transmembrane transport1
cellular process1
aspartate transmembrane transport1
monoatomic cation transmembrane transport1
amino acid:monoatomic cation symporter activity1
solute:proton symporter activity1
dicarboxylic acid transmembrane transporter activity1
L-glutamate transmembrane transport1
C4-dicarboxylate transmembrane transporter activity1
L-aspartate transmembrane transport1
binding1
secondary active transmembrane transporter activity1
cytoplasm1
intracellular membrane-bounded organelle1
organelle inner membrane1
mitochondrial membrane1
cellular anatomical structure1

Protein interactions and networks

STRING

872 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
SLC25A18GCP02774907
SLC25A18ST6GALNAC1Q9NSC7795
SLC25A18GUCA1CO95843760
SLC25A18GUCA1BQ9UMX6696
SLC25A18NDRG1Q92597646
SLC25A18MTCH1Q9NZJ7571
SLC25A18C3P01024551
SLC25A18SCINQ9Y6U3548
SLC25A18MTCH2Q9Y6C9530
SLC25A18GSNP06396506
SLC25A18ALBP02768500
SLC25A18A6NFB4A6NFB4485
SLC25A18AFPP02771475
SLC25A18CECR2Q9BXF3462
SLC25A18CYP2R1Q6VVX0447

IntAct

33 interactions, top by confidence:

ABTypeScore
HSPD1NUDT19psi-mi:“MI:0914”(association)0.710
SLC25A18GOPCpsi-mi:“MI:0915”(physical association)0.560
GOPCSLC25A18psi-mi:“MI:0915”(physical association)0.560
KRTAP9-3SLC25A18psi-mi:“MI:0915”(physical association)0.560
CYSRT1SLC25A18psi-mi:“MI:0915”(physical association)0.560
KRTAP13-2SLC25A18psi-mi:“MI:0915”(physical association)0.560
KRTAP19-6SLC25A18psi-mi:“MI:0915”(physical association)0.560
SLC25A22DNLZpsi-mi:“MI:0914”(association)0.530
PJA1SMC5psi-mi:“MI:0914”(association)0.530
FLT4ILVBLpsi-mi:“MI:0914”(association)0.420
SLC25A18GAPDHSpsi-mi:“MI:0915”(physical association)0.400
FGRHNRNPCL1psi-mi:“MI:0914”(association)0.350
MAP2K5DNAJA2psi-mi:“MI:0914”(association)0.350
LCKCDK1psi-mi:“MI:0914”(association)0.350
MAP2K5MAGEB2psi-mi:“MI:0914”(association)0.350
LCKUQCRQpsi-mi:“MI:0914”(association)0.350
Ppsi-mi:“MI:0914”(association)0.350
SLC16A11ESYT2psi-mi:“MI:0914”(association)0.350
SLC25A18HSPA8psi-mi:“MI:0914”(association)0.350
SLC25A18FAM83Bpsi-mi:“MI:0914”(association)0.350
P/VESYT2psi-mi:“MI:0914”(association)0.350
MRPL58psi-mi:“MI:0914”(association)0.350
SLC25A18KRTAP9-3psi-mi:“MI:0915”(physical association)0.000
SLC25A18CYSRT1psi-mi:“MI:0915”(physical association)0.000
SLC25A18KRTAP13-2psi-mi:“MI:0915”(physical association)0.000

BioGRID (46): SLC25A18 (Two-hybrid), SLC25A18 (Affinity Capture-MS), SLC25A18 (Affinity Capture-MS), SLC25A18 (Affinity Capture-MS), SLC25A18 (Affinity Capture-MS), SLC25A18 (Two-hybrid), KRTAP19-6 (Two-hybrid), CYSRT1 (Two-hybrid), KRTAP9-3 (Two-hybrid), SLC25A18 (Affinity Capture-MS), SLC25A18 (Affinity Capture-MS), SLC25A18 (Affinity Capture-MS), SLC25A18 (Affinity Capture-MS), SLC25A18 (Affinity Capture-MS), SLC25A18 (Affinity Capture-MS)

ESM2 similar proteins: A0A0G2K309, A0A1D6N272, A3KPP4, G3XP90, G3YD89, O13844, P04575, P04633, P12234, P12242, P16036, P33303, Q08DK7, Q0VCH6, Q1LZB3, Q27257, Q29RM1, Q3KQZ1, Q3TZX3, Q505J6, Q58DS3, Q5HZE0, Q5IS35, Q5NVC1, Q5R7W2, Q5SWT3, Q6AYL0, Q6DFK2, Q6P036, Q6P316, Q7K566, Q8BGP6, Q8BL03, Q8BZ09, Q8N8R3, Q8TBP6, Q8VEM8, Q93XM7, Q99JD3, Q9BSK2

Diamond homologs: A0A0G2K5L2, A2ADF7, A4QNX2, B0G143, F1LX07, F1LZW6, F1RFX9, O13844, O43772, O75746, P16261, P39953, Q02978, Q08DK4, Q0II44, Q12482, Q1DRJ3, Q21153, Q26365, Q3KQZ1, Q3TZX3, Q4V8K4, Q505J6, Q54QN2, Q54RB9, Q552L9, Q58DS3, Q5B717, Q5RBC8, Q5RD81, Q5SWT3, Q5XIF9, Q5ZKP7, Q66L49, Q68F18, Q6ZT89, Q75AH6, Q7PQV7, Q86AV5, Q8BH59

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

16 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance11
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

2173 predictions. Top by Δscore:

VariantEffectΔscore
22:17563714:G:GGdonor_gain1.0000
22:17581035:A:AGacceptor_gain1.0000
22:17581036:G:GAacceptor_gain1.0000
22:17581036:GC:Gacceptor_gain1.0000
22:17581140:A:Tdonor_gain1.0000
22:17581155:GGAAT:Gdonor_gain1.0000
22:17581156:GAAT:Gdonor_gain1.0000
22:17581156:GAATG:Gdonor_gain1.0000
22:17581157:A:Tdonor_gain1.0000
22:17581158:AT:Adonor_gain1.0000
22:17581160:G:GGdonor_gain1.0000
22:17582556:C:Gacceptor_gain1.0000
22:17582559:CCA:Cacceptor_loss1.0000
22:17582561:A:AGacceptor_gain1.0000
22:17582561:A:Cacceptor_loss1.0000
22:17582561:AG:Aacceptor_gain1.0000
22:17582561:AGG:Aacceptor_gain1.0000
22:17582561:AGGG:Aacceptor_gain1.0000
22:17582562:G:Aacceptor_gain1.0000
22:17582562:G:GAacceptor_gain1.0000
22:17582562:GGG:Gacceptor_gain1.0000
22:17582562:GGGG:Gacceptor_gain1.0000
22:17582562:GGGGC:Gacceptor_gain1.0000
22:17582646:G:Tdonor_gain1.0000
22:17582646:GAAGA:Gdonor_gain1.0000
22:17582649:GATGG:Gdonor_gain1.0000
22:17582650:A:Gdonor_gain1.0000
22:17582650:ATGG:Adonor_loss1.0000
22:17582652:GG:Gdonor_gain1.0000
22:17582652:GGGTA:Gdonor_loss1.0000

AlphaMissense

2042 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
22:17590171:T:CF295L0.996
22:17590173:T:AF295L0.996
22:17590173:T:GF295L0.996
22:17581089:T:CC25R0.995
22:17581095:T:CF27L0.994
22:17581097:C:AF27L0.994
22:17581097:C:GF27L0.994
22:17581115:G:CK33N0.994
22:17581115:G:TK33N0.994
22:17587935:T:CF196L0.994
22:17587937:C:AF196L0.994
22:17587937:C:GF196L0.994
22:17590163:C:AA292E0.994
22:17587950:T:CF201L0.993
22:17587952:C:AF201L0.993
22:17587952:C:GF201L0.993
22:17587951:T:GF201C0.992
22:17589597:A:CK246N0.992
22:17589597:A:TK246N0.992
22:17590166:C:AP293H0.992
22:17590175:G:AG296E0.992
22:17581080:G:AG22R0.991
22:17581080:G:CG22R0.991
22:17583506:G:CK127N0.991
22:17583506:G:TK127N0.991
22:17588032:G:AG228D0.991
22:17588053:C:AA235D0.991
22:17588076:G:CD243H0.991
22:17589602:G:CR248P0.991
22:17581069:C:AA18E0.990

dbSNP variants (sampled 300 via entrez): RS1000136944 (22:17574974 T>C), RS1000187943 (22:17567423 T>C,G), RS1000208610 (22:17584178 G>C), RS1000222450 (22:17589484 A>C,G), RS1000307803 (22:17589207 G>A), RS1000308988 (22:17565089 GTTTTGTTTTT>G), RS1000333019 (22:17565360 C>T), RS1000437762 (22:17564977 G>A,C), RS1000558609 (22:17590744 G>A), RS1000668007 (22:17568405 G>C), RS1000809240 (22:17580033 A>C), RS1000861491 (22:17580389 A>G,T), RS1000891834 (22:17565205 C>T), RS1000893323 (22:17584403 G>A,T), RS1001131960 (22:17590949 T>C)

Disease associations

OMIM: gene MIM:609303 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

GtoPdb / IUPHAR curated pharmacology

(IUPHAR/BPS Guide to Pharmacology — expert-curated)

Target class: transporter — Mitochondrial amino acid transporter subfamily

CTD chemical–gene interactions

24 total (human), top 24 by PubMed support.

ChemicalActions (top 5)PubMed papers
bisphenol Adecreases methylation, affects cotreatment, increases expression2
Acetaminophenincreases expression, decreases expression2
Nickeldecreases expression2
Cyclosporinedecreases expression2
aristolochic acid Iincreases expression1
sodium arsenitedecreases expression1
perfluoro-n-nonanoic aciddecreases expression1
bisphenol Sdecreases expression, affects cotreatment1
jinfukangaffects cotreatment, decreases expression1
Amiodaroneincreases expression1
Benzo(a)pyreneaffects methylation, increases methylation1
Cisplatinaffects cotreatment, decreases expression1
Dichlorodiphenyl Dichloroethyleneincreases expression1
Dexamethasoneaffects cotreatment, increases expression, decreases expression1
Estradiolaffects cotreatment, decreases expression1
Indomethacinincreases expression, decreases expression, affects cotreatment1
Tetrachlorodibenzodioxindecreases expression1
Thiramdecreases expression1
Valproic Aciddecreases expression1
1-Methyl-3-isobutylxanthineaffects cotreatment, increases expression, decreases expression1
Aflatoxin B1decreases expression1
Palmitic Aciddecreases expression1
Okadaic Aciddecreases expression1
Acrylamideincreases expression1

Cellosaurus cell lines

5 cell lines: 5 cancer cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_D4SIHuH7-SLC25A18-KO-c10Cancer cell lineMale
CVCL_D4SJHuH7-SLC25A18-KO-c3Cancer cell lineMale
CVCL_D4SKHuH7-SLC25A18-KO-c9Cancer cell lineMale
CVCL_TM19HAP1 SLC25A18 (-) 1Cancer cell lineMale
CVCL_TM20HAP1 SLC25A18 (-) 2Cancer cell lineMale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.